Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2025 ,inter alia, to consider and approve Unaudited standalone and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bharat Parenterals Ltd has informed BSE that its Board of Directors will meet on Monday, July 28, 2025 at the company's registered office in Vadodada. The meeting will consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2025 (Q1 FY2026). The trading window for designated persons has been closed from July 1, 2025 until 48 hours after the results are declared. The notice is also available on the company's website at www.bplindia.in.
This is a routine advance intimation with no direct impact on shareholders or stock price. Investors should watch for the actual Q1 FY2026 results on or after July 28, 2025 for any meaningful performance signals.